BIORTUS

[ Anti-cancer preparations; Antibacterial pharmaceuticals; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, diabetes, hypertension, bone diseases, asthma and allergies; Chemical preparations for sanitary purposes; Enzymes for veterinary purposes; Ferments for pharmaceutical purposes; Opium alkaloid preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for use in chemotherapy; Reagents for medical use; Vaccines ]

Biological research; Chemistry consultation; [ Material testing; Packaging design; Physics research; ] Product quality testing; Research and development of new products